Compazine and Neosar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Compazine (prochlorperazine maleate) and Neosar (cyclophosphamide). Common drug interactions include alopecia among females.
The phase IV clinical study analyzes what interactions people have when they take Compazine and Neosar. It is created by eHealthMe based on reports of 169 people who take the same drugs from the FDA, and is updated regularly.
What is Compazine?
Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.
What is Neosar?
Neosar has active ingredients of cyclophosphamide. eHealthMe is studying from 12,352 Neosar users. Check the latest studies of Neosar.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
169 people who take Compazine and Neosar together, and have interactions are studied.
What are the common drug interactions of Compazine and Neosar, by gender? *
What are the common drug interactions of Compazine and Neosar, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Compazine and Neosar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Compazine and Neosar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Compazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Neosar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Compazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neosar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on prochlorperazine maleate and cyclophosphamide (the active ingredients of Compazine and Neosar, respectively), and Compazine and Neosar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Paroxysmal Nocturnal Haemoglobinuria and Bacterial Infection - 11 seconds ago
- Could Wellbutrin cause Bacterial Sepsis? - 13 seconds ago
- Could Lasix cause Insulin-Requiring Type 2 Diabetes Mellitus? - 15 seconds ago
- Lacosamide and Electrocardiogram Qt Prolonged for Women aged 20-29 - 16 seconds ago
- Could Nexium cause Pseudotumor Cerebri? - 19 seconds ago
- Could Quetiapine Fumarate cause Tumor? - 23 seconds ago
- Apixaban and Famotidine drug interactions for women aged 60+ - a minute ago
- Could Ammonium Lactate cause Cellulitis Aggravated? - a minute ago
- Could Methotrexate cause Measles? - 2 minutes ago
- Could Ventolin Hfa cause Hearing Loss? - 2 minutes ago